Equillium Inc (EQ)
0.6925
-0.09
(-11.26%)
USD |
NASDAQ |
Nov 14, 13:01
Equillium Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.2581 |
| December 31, 2022 | 0.2803 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
0.2803
Maximum
Dec 2022
0.0769
Average
--
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Matinas BioPharma Holdings Inc | -- |
| Tenon Medical Inc | 0.00 |
| Alphatec Holdings Inc | -387.46 |
| Madrigal Pharmaceuticals Inc | 0.1507 |
| Spero Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 42.86M |
| Total Liabilities (Quarterly) | 20.43M |
| Shareholders Equity (Quarterly) | 22.43M |
| Current Ratio | 2.077 |
| Net Debt Paydown Yield | 6.15% |